APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ipilimumab Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Ipilimumab Injection Market Analysis and Forecast 2026-2032

27 December 2025196 pages

Choose your research edition.

Industry ResearchIpilimumab Injection Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Ipilimumab Injection Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Ipilimumab Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ipilimumab Injection Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Ipilimumab Injection Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Ipilimumab Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Ipilimumab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Ipilimumab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Ipilimumab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Ipilimumab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Ipilimumab Injection include Bristol Myers Squibb. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Ipilimumab Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Ipilimumab Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Ipilimumab Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ipilimumab Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ipilimumab Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Ipilimumab Injection sales, projected growth trends, production technology, application and end-user industry.

Ipilimumab Injection Segment by Company

Bristol Myers Squibb

Ipilimumab Injection Segment by Type

50mg per Vial

200mg per Vial

Ipilimumab Injection Segment by Application

Malignant Thymic Mesothelioma

Non-small Cell Lung Cancer

Hepatocellular Carcinoma

Melanoma

Colorectal Cancer

Renal Cell Carcinoma

Other

Ipilimumab Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ipilimumab Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ipilimumab Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ipilimumab Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Ipilimumab Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Ipilimumab Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ipilimumab Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ipilimumab Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 50mg per Vial Major Manufacturers Table 3. 200mg per Vial Major Manufacturers Table 4. Global Ipilimumab Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Malignant Thymic Mesothelioma Major Manufacturers Table 6. Non-small Cell Lung Cancer Major Manufacturers Table 7. Hepatocellular Carcinoma Major Manufacturers Table 8. Melanoma Major Manufacturers Table 9. Colorectal Cancer Major Manufacturers Table 10. Renal Cell Carcinoma Major Manufacturers Table 11. Other Major Manufacturers Table 12. Ipilimumab Injection Industry Trends Table 13. Ipilimumab Injection Industry Drivers Table 14. Ipilimumab Injection Industry Opportunities and Challenges Table 15. Ipilimumab Injection Industry Restraints Table 16. Global Ipilimumab Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Ipilimumab Injection Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Ipilimumab Injection Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Ipilimumab Injection Revenue Market Share by Region (2021-2026) Table 20. Global Ipilimumab Injection Revenue Market Share by Region (2027-2032) Table 21. Global Ipilimumab Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 22. Global Ipilimumab Injection Sales by Region (2021-2026) & (K Units) Table 23. Global Ipilimumab Injection Sales by Region (2027-2032) & (K Units) Table 24. Global Ipilimumab Injection Sales Market Share by Region (2021-2026) Table 25. Global Ipilimumab Injection Sales Market Share by Region (2027-2032) Table 26. Global Ipilimumab Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Ipilimumab Injection Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Ipilimumab Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Ipilimumab Injection Sales Market Share by Manufacturers (2021-2026) Table 30. Global Ipilimumab Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 31. Global Ipilimumab Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Ipilimumab Injection Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Ipilimumab Injection Manufacturers, Product Type & Application Table 34. Global Ipilimumab Injection Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Ipilimumab Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Ipilimumab Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Ipilimumab Injection Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Ipilimumab Injection Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Ipilimumab Injection Revenue Market Share by Type (2021-2026) Table 41. Global Ipilimumab Injection Revenue Market Share by Type (2027-2032) Table 42. Global Ipilimumab Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 43. Global Ipilimumab Injection Sales by Type (2021-2026) & (K Units) Table 44. Global Ipilimumab Injection Sales by Type (2027-2032) & (K Units) Table 45. Global Ipilimumab Injection Sales Market Share by Type (2021-2026) Table 46. Global Ipilimumab Injection Sales Market Share by Type (2027-2032) Table 47. Global Ipilimumab Injection Price by Type (2021-2026) & (US$/Unit) Table 48. Global Ipilimumab Injection Price by Type (2027-2032) & (US$/Unit) Table 49. Global Ipilimumab Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Ipilimumab Injection Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Ipilimumab Injection Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Ipilimumab Injection Revenue Market Share by Application (2021-2026) Table 53. Global Ipilimumab Injection Revenue Market Share by Application (2027-2032) Table 54. Global Ipilimumab Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 55. Global Ipilimumab Injection Sales by Application (2021-2026) & (K Units) Table 56. Global Ipilimumab Injection Sales by Application (2027-2032) & (K Units) Table 57. Global Ipilimumab Injection Sales Market Share by Application (2021-2026) Table 58. Global Ipilimumab Injection Sales Market Share by Application (2027-2032) Table 59. Global Ipilimumab Injection Price by Application (2021-2026) & (US$/Unit) Table 60. Global Ipilimumab Injection Price by Application (2027-2032) & (US$/Unit) Table 61. Bristol Myers Squibb Company Information Table 62. Bristol Myers Squibb Business Overview Table 63. Bristol Myers Squibb Ipilimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Bristol Myers Squibb Ipilimumab Injection Product Portfolio Table 65. Bristol Myers Squibb Recent Development Table 66. North America Ipilimumab Injection Revenue by Type (2021-2026) & (US$ Million) Table 67. North America Ipilimumab Injection Revenue by Type (2027-2032) & (US$ Million) Table 68. North America Ipilimumab Injection Sales by Type (2021-2026) & (K Units) Table 69. North America Ipilimumab Injection Sales by Type (2027-2032) & (K Units) Table 70. North America Ipilimumab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 71. North America Ipilimumab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 72. North America Ipilimumab Injection Revenue by Application (2021-2026) & (US$ Million) Table 73. North America Ipilimumab Injection Revenue by Application (2027-2032) & (US$ Million) Table 74. North America Ipilimumab Injection Sales by Application (2021-2026) & (K Units) Table 75. North America Ipilimumab Injection Sales by Application (2027-2032) & (K Units) Table 76. North America Ipilimumab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 77. North America Ipilimumab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 78. North America Ipilimumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 79. North America Ipilimumab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 80. North America Ipilimumab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 81. North America Ipilimumab Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 82. North America Ipilimumab Injection Sales by Country (2021-2026) & (K Units) Table 83. North America Ipilimumab Injection Sales by Country (2027-2032) & (K Units) Table 84. North America Ipilimumab Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 85. North America Ipilimumab Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 86. United States Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 87. Canada Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 88. Mexico Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 89. Europe Ipilimumab Injection Revenue by Type (2021-2026) & (US$ Million) Table 90. Europe Ipilimumab Injection Revenue by Type (2027-2032) & (US$ Million) Table 91. Europe Ipilimumab Injection Sales by Type (2021-2026) & (K Units) Table 92. Europe Ipilimumab Injection Sales by Type (2027-2032) & (K Units) Table 93. Europe Ipilimumab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 94. Europe Ipilimumab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 95. Europe Ipilimumab Injection Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe Ipilimumab Injection Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe Ipilimumab Injection Sales by Application (2021-2026) & (K Units) Table 98. Europe Ipilimumab Injection Sales by Application (2027-2032) & (K Units) Table 99. Europe Ipilimumab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 100. Europe Ipilimumab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 101. Europe Ipilimumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe Ipilimumab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 103. Europe Ipilimumab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 104. Europe Ipilimumab Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 105. Europe Ipilimumab Injection Sales by Country (2021-2026) & (K Units) Table 106. Europe Ipilimumab Injection Sales by Country (2027-2032) & (K Units) Table 107. Europe Ipilimumab Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 108. Europe Ipilimumab Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 109. Germany Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 110. France Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 111. U.K. Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 112. Italy Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 113. Russia Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 114. Spain Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 115. Netherlands Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 116. Switzerland Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 117. Sweden Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 118. Poland Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 119. China Ipilimumab Injection Revenue by Type (2021-2026) & (US$ Million) Table 120. China Ipilimumab Injection Revenue by Type (2027-2032) & (US$ Million) Table 121. China Ipilimumab Injection Sales by Type (2021-2026) & (K Units) Table 122. China Ipilimumab Injection Sales by Type (2027-2032) & (K Units) Table 123. China Ipilimumab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 124. China Ipilimumab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 125. China Ipilimumab Injection Revenue by Application (2021-2026) & (US$ Million) Table 126. China Ipilimumab Injection Revenue by Application (2027-2032) & (US$ Million) Table 127. China Ipilimumab Injection Sales by Application (2021-2026) & (K Units) Table 128. China Ipilimumab Injection Sales by Application (2027-2032) & (K Units) Table 129. China Ipilimumab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 130. China Ipilimumab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 131. Asia Ipilimumab Injection Revenue by Type (2021-2026) & (US$ Million) Table 132. Asia Ipilimumab Injection Revenue by Type (2027-2032) & (US$ Million) Table 133. Asia Ipilimumab Injection Sales by Type (2021-2026) & (K Units) Table 134. Asia Ipilimumab Injection Sales by Type (2027-2032) & (K Units) Table 135. Asia Ipilimumab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 136. Asia Ipilimumab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 137. Asia Ipilimumab Injection Revenue by Application (2021-2026) & (US$ Million) Table 138. Asia Ipilimumab Injection Revenue by Application (2027-2032) & (US$ Million) Table 139. Asia Ipilimumab Injection Sales by Application (2021-2026) & (K Units) Table 140. Asia Ipilimumab Injection Sales by Application (2027-2032) & (K Units) Table 141. Asia Ipilimumab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 142. Asia Ipilimumab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 143. Asia Ipilimumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Asia Ipilimumab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 145. Asia Ipilimumab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 146. Asia Ipilimumab Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 147. Asia Ipilimumab Injection Sales by Country (2021-2026) & (K Units) Table 148. Asia Ipilimumab Injection Sales by Country (2027-2032) & (K Units) Table 149. Asia Ipilimumab Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 150. Asia Ipilimumab Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 151. Japan Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 152. South Korea Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 153. India Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 154. Australia Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 155. Taiwan Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 156. Southeast Asia Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 157. SAMEA Ipilimumab Injection Revenue by Type (2021-2026) & (US$ Million) Table 158. SAMEA Ipilimumab Injection Revenue by Type (2027-2032) & (US$ Million) Table 159. SAMEA Ipilimumab Injection Sales by Type (2021-2026) & (K Units) Table 160. SAMEA Ipilimumab Injection Sales by Type (2027-2032) & (K Units) Table 161. SAMEA Ipilimumab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 162. SAMEA Ipilimumab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 163. SAMEA Ipilimumab Injection Revenue by Application (2021-2026) & (US$ Million) Table 164. SAMEA Ipilimumab Injection Revenue by Application (2027-2032) & (US$ Million) Table 165. SAMEA Ipilimumab Injection Sales by Application (2021-2026) & (K Units) Table 166. SAMEA Ipilimumab Injection Sales by Application (2027-2032) & (K Units) Table 167. SAMEA Ipilimumab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 168. SAMEA Ipilimumab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 169. SAMEA Ipilimumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. SAMEA Ipilimumab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. SAMEA Ipilimumab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. SAMEA Ipilimumab Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 173. SAMEA Ipilimumab Injection Sales by Country (2021-2026) & (K Units) Table 174. SAMEA Ipilimumab Injection Sales by Country (2027-2032) & (K Units) Table 175. SAMEA Ipilimumab Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 176. SAMEA Ipilimumab Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 177. Brazil Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 178. Argentina Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 179. Chile Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 180. Colombia Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 181. Peru Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 182. Saudi Arabia Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 183. Israel Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 184. UAE Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 185. Turkey Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 186. Iran Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 187. Egypt Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Table 188. Key Raw Materials Table 189. Raw Materials Key Suppliers Table 190. Ipilimumab Injection Distributors List Table 191. Ipilimumab Injection Customers List Table 192. Research Programs/Design for This Report Table 193. Authors List of This Report Table 194. Secondary Sources Table 195. Primary Sources List of Figures Figure 1. Ipilimumab Injection Image Figure 2. Global Ipilimumab Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ipilimumab Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 50mg per Vial Image Figure 5. 200mg per Vial Image Figure 6. Global Ipilimumab Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Ipilimumab Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Malignant Thymic Mesothelioma Image Figure 9. Non-small Cell Lung Cancer Image Figure 10. Hepatocellular Carcinoma Image Figure 11. Melanoma Image Figure 12. Colorectal Cancer Image Figure 13. Renal Cell Carcinoma Image Figure 14. Other Image Figure 15. Global Ipilimumab Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Ipilimumab Injection Revenue (2021-2032) & (US$ Million) Figure 17. Global Ipilimumab Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Ipilimumab Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Ipilimumab Injection Revenue Market Share by Region (2021-2032) Figure 20. Global Ipilimumab Injection Sales (2021-2032) & (K Units) Figure 21. Global Ipilimumab Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 22. Global Ipilimumab Injection Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Ipilimumab Injection Sales YoY (2021-2032) & (K Units) Figure 24. Europe Ipilimumab Injection Sales YoY (2021-2032) & (K Units) Figure 25. China Ipilimumab Injection Sales YoY (2021-2032) & (K Units) Figure 26. Asia (Excluding China) Ipilimumab Injection Sales YoY (2021-2032) & (K Units) Figure 27. South America, Middle East and Africa Ipilimumab Injection Sales YoY (2021-2032) & (K Units) Figure 28. Global Ipilimumab Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Ipilimumab Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Ipilimumab Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Ipilimumab Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Ipilimumab Injection Revenue Market Share by Type (2021-2032) Figure 34. Global Ipilimumab Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 35. Global Ipilimumab Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Ipilimumab Injection Sales Market Share by Type (2021-2032) Figure 37. Global Ipilimumab Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Ipilimumab Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Ipilimumab Injection Revenue Market Share by Application (2021-2032) Figure 40. Global Ipilimumab Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 41. Global Ipilimumab Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Ipilimumab Injection Sales Market Share by Application (2021-2032) Figure 43. North America Ipilimumab Injection Revenue Share by Type (2021-2032) Figure 44. North America Ipilimumab Injection Sales Share by Type (2021-2032) Figure 45. North America Ipilimumab Injection Revenue Share by Application (2021-2032) Figure 46. North America Ipilimumab Injection Sales Share by Application (2021-2032) Figure 47. North America Ipilimumab Injection Revenue Share by Country (2021-2032) Figure 48. North America Ipilimumab Injection Sales Share by Country (2021-2032) Figure 49. Europe Ipilimumab Injection Revenue Share by Type (2021-2032) Figure 50. Europe Ipilimumab Injection Sales Share by Type (2021-2032) Figure 51. Europe Ipilimumab Injection Revenue Share by Application (2021-2032) Figure 52. Europe Ipilimumab Injection Sales Share by Application (2021-2032) Figure 53. Europe Ipilimumab Injection Revenue Share by Country (2021-2032) Figure 54. Europe Ipilimumab Injection Sales Share by Country (2021-2032) Figure 55. China Ipilimumab Injection Revenue Share by Type (2021-2032) Figure 56. China Ipilimumab Injection Sales Share by Type (2021-2032) Figure 57. China Ipilimumab Injection Revenue Share by Application (2021-2032) Figure 58. China Ipilimumab Injection Sales Share by Application (2021-2032) Figure 59. Asia Ipilimumab Injection Revenue Share by Type (2021-2032) Figure 60. Asia Ipilimumab Injection Sales Share by Type (2021-2032) Figure 61. Asia Ipilimumab Injection Revenue Share by Application (2021-2032) Figure 62. Asia Ipilimumab Injection Sales Share by Application (2021-2032) Figure 63. Asia Ipilimumab Injection Revenue Share by Country (2021-2032) Figure 64. Asia Ipilimumab Injection Sales Share by Country (2021-2032) Figure 65. SAMEA Ipilimumab Injection Revenue Share by Type (2021-2032) Figure 66. SAMEA Ipilimumab Injection Sales Share by Type (2021-2032) Figure 67. SAMEA Ipilimumab Injection Revenue Share by Application (2021-2032) Figure 68. SAMEA Ipilimumab Injection Sales Share by Application (2021-2032) Figure 69. SAMEA Ipilimumab Injection Revenue Share by Country (2021-2032) Figure 70. SAMEA Ipilimumab Injection Sales Share by Country (2021-2032) Figure 71. Ipilimumab Injection Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Ipilimumab Injection Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg per Vial
  • 200mg per Vial
Applications
  • Malignant Thymic Mesothelioma
  • Non-small Cell Lung Cancer
  • Hepatocellular Carcinoma
  • Melanoma
  • Colorectal Cancer
  • Renal Cell Carcinoma
  • Other
Companies covered
  • Bristol Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Ipilimumab Injection Market by Type
  3. 1.2.1 Global Ipilimumab Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 50mg per Vial
  5. 1.2.3 200mg per Vial
  6. 1.3 Ipilimumab Injection Market by Application
  7. 1.3.1 Global Ipilimumab Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Malignant Thymic Mesothelioma
  9. 1.3.3 Non-small Cell Lung Cancer
  10. 1.3.4 Hepatocellular Carcinoma
  11. 1.3.5 Melanoma
  12. 1.3.6 Colorectal Cancer
  13. 1.3.7 Renal Cell Carcinoma
  14. 1.3.8 Other
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Ipilimumab Injection Market Dynamics
  1. 2.1 Ipilimumab Injection Industry Trends
  2. 2.2 Ipilimumab Injection Industry Drivers
  3. 2.3 Ipilimumab Injection Industry Opportunities and Challenges
  4. 2.4 Ipilimumab Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Ipilimumab Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Ipilimumab Injection Revenue by Region
  3. 3.2.1 Global Ipilimumab Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Ipilimumab Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Ipilimumab Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Ipilimumab Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Ipilimumab Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Ipilimumab Injection Sales by Region
  9. 3.4.1 Global Ipilimumab Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Ipilimumab Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Ipilimumab Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Ipilimumab Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Ipilimumab Injection Revenue by Manufacturers
  2. 4.1.1 Global Ipilimumab Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Ipilimumab Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Ipilimumab Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Ipilimumab Injection Sales by Manufacturers
  6. 4.2.1 Global Ipilimumab Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Ipilimumab Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Ipilimumab Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Ipilimumab Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Ipilimumab Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Ipilimumab Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Ipilimumab Injection Manufacturers, Product Type & Application
  13. 4.7 Global Ipilimumab Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Ipilimumab Injection Market CR5 and HHI
  16. 4.8.2 2025 Ipilimumab Injection Tier 1, Tier 2, and Tier 3
5 Ipilimumab Injection Market by Type
  1. 5.1 Global Ipilimumab Injection Revenue by Type
  2. 5.1.1 Global Ipilimumab Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Ipilimumab Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Ipilimumab Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Ipilimumab Injection Sales by Type
  6. 5.2.1 Global Ipilimumab Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ipilimumab Injection Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Ipilimumab Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Ipilimumab Injection Price by Type
6 Ipilimumab Injection Market by Application
  1. 6.1 Global Ipilimumab Injection Revenue by Application
  2. 6.1.1 Global Ipilimumab Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Ipilimumab Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Ipilimumab Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Ipilimumab Injection Sales by Application
  6. 6.2.1 Global Ipilimumab Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Ipilimumab Injection Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Ipilimumab Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Ipilimumab Injection Price by Application
7 Company Profiles
  1. 7.1 Bristol Myers Squibb
  2. 7.1.1 Bristol Myers Squibb Company Information
  3. 7.1.2 Bristol Myers Squibb Business Overview
  4. 7.1.3 Bristol Myers Squibb Ipilimumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bristol Myers Squibb Ipilimumab Injection Product Portfolio
  6. 7.1.5 Bristol Myers Squibb Recent Developments
8 North America
  1. 8.1 North America Ipilimumab Injection Market Size by Type
  2. 8.1.1 North America Ipilimumab Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Ipilimumab Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Ipilimumab Injection Price by Type (2021-2032)
  5. 8.2 North America Ipilimumab Injection Market Size by Application
  6. 8.2.1 North America Ipilimumab Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Ipilimumab Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Ipilimumab Injection Price by Application (2021-2032)
  9. 8.3 North America Ipilimumab Injection Market Size by Country
  10. 8.3.1 North America Ipilimumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Ipilimumab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Ipilimumab Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Ipilimumab Injection Market Size by Type
  2. 9.1.1 Europe Ipilimumab Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Ipilimumab Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Ipilimumab Injection Price by Type (2021-2032)
  5. 9.2 Europe Ipilimumab Injection Market Size by Application
  6. 9.2.1 Europe Ipilimumab Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Ipilimumab Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Ipilimumab Injection Price by Application (2021-2032)
  9. 9.3 Europe Ipilimumab Injection Market Size by Country
  10. 9.3.1 Europe Ipilimumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Ipilimumab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Ipilimumab Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Ipilimumab Injection Market Size by Type
  2. 10.1.1 China Ipilimumab Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Ipilimumab Injection Sales by Type (2021-2032)
  4. 10.1.3 China Ipilimumab Injection Price by Type (2021-2032)
  5. 10.2 China Ipilimumab Injection Market Size by Application
  6. 10.2.1 China Ipilimumab Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Ipilimumab Injection Sales by Application (2021-2032)
  8. 10.2.3 China Ipilimumab Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Ipilimumab Injection Market Size by Type
  2. 11.1.1 Asia Ipilimumab Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Ipilimumab Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Ipilimumab Injection Price by Type (2021-2032)
  5. 11.2 Asia Ipilimumab Injection Market Size by Application
  6. 11.2.1 Asia Ipilimumab Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Ipilimumab Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Ipilimumab Injection Price by Application (2021-2032)
  9. 11.3 Asia Ipilimumab Injection Market Size by Country
  10. 11.3.1 Asia Ipilimumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Ipilimumab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Ipilimumab Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Ipilimumab Injection Market Size by Type
  2. 12.1.1 SAMEA Ipilimumab Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Ipilimumab Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Ipilimumab Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Ipilimumab Injection Market Size by Application
  6. 12.2.1 SAMEA Ipilimumab Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Ipilimumab Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Ipilimumab Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Ipilimumab Injection Market Size by Country
  10. 12.3.1 SAMEA Ipilimumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Ipilimumab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Ipilimumab Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Ipilimumab Injection Value Chain Analysis
  2. 13.1.1 Ipilimumab Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Ipilimumab Injection Production Mode & Process
  6. 13.2 Ipilimumab Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Ipilimumab Injection Distributors
  9. 13.2.3 Ipilimumab Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst